Liqin Qi

423 total citations
14 papers, 302 citations indexed

About

Liqin Qi is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Liqin Qi has authored 14 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Liqin Qi's work include Parkinson's Disease Mechanisms and Treatments (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Autophagy in Disease and Therapy (2 papers). Liqin Qi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Autophagy in Disease and Therapy (2 papers). Liqin Qi collaborates with scholars based in China. Liqin Qi's co-authors include Libin Liu, Jiaping Zheng, Xiaodong Pan, Li Wu, Jianxing Zhou, Yu Zhou, Xiaoying Liu, Chen Zhou, Lianming Liao and Lijuan Wu and has published in prestigious journals such as Free Radical Biology and Medicine, European Journal of Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Liqin Qi

11 papers receiving 301 citations

Peers

Liqin Qi
Liqin Qi
Citations per year, relative to Liqin Qi Liqin Qi (= 1×) peers Chaitanya Chakravarthi Gali

Countries citing papers authored by Liqin Qi

Since Specialization
Citations

This map shows the geographic impact of Liqin Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqin Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqin Qi more than expected).

Fields of papers citing papers by Liqin Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqin Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqin Qi. The network helps show where Liqin Qi may publish in the future.

Co-authorship network of co-authors of Liqin Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Liqin Qi. A scholar is included among the top collaborators of Liqin Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqin Qi. Liqin Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Qi, Liqin, et al.. (2025). Gut microbiota mediates semaglutide attenuation of diabetes-associated cognitive decline. Neurotherapeutics. 22(5). e00615–e00615.
2.
3.
Ma, Li, Liqin Qi, Sujie Ke, et al.. (2025). Triple signal biosensing platform for ultrasensitive and wide-range detection of HLA gene targets. Analytical Methods. 17(36). 7280–7286.
4.
Huang, Cuihua, Lijing Wang, Kejun Wu, et al.. (2023). Mitophagy disorder mediates cardiac deterioration induced by severe hypoglycemia in diabetic mice. Molecular and Cellular Endocrinology. 575. 111994–111994. 3 indexed citations
5.
Huang, Cuihua, Wenrong Zheng, Liqin Qi, et al.. (2023). Activation of mitophagy improves cognitive dysfunction in diabetic mice with recurrent non-severe hypoglycemia. Molecular and Cellular Endocrinology. 580. 112109–112109. 1 indexed citations
6.
Ke, Sujie, Liqin Qi, Xiaoying Liu, et al.. (2023). Potential risk factors for mild cognitive impairment among patients with type 2 diabetes experiencing hypoglycemia. Diabetes Research and Clinical Practice. 207. 111036–111036. 3 indexed citations
7.
Qi, Liqin, et al.. (2023). Clouclip combined with a questionnaire on the influence factors of myopia in children. Frontiers in Pediatrics. 11. 1228257–1228257. 6 indexed citations
8.
Chen, Jian, et al.. (2022). Microwave ablation therapy assisted by artificial pneumothorax and artificial hydrothorax for lung cancer adjacent to the vital organs. Frontiers in Oncology. 12. 981789–981789. 3 indexed citations
9.
Qi, Liqin, Zhou Chen, Donghai Lin, et al.. (2022). Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells. NeuroToxicology. 92. 166–179. 17 indexed citations
10.
Chen, Zhou, Ruiyu Chen, Wenrong Zheng, et al.. (2022). SIRT3 alleviates mitochondrial dysfunction induced by recurrent low glucose and improves the supportive function of astrocytes to neurons. Free Radical Biology and Medicine. 193(Pt 1). 405–420. 9 indexed citations
11.
Zheng, Jiaping, Liqin Qi, Li Wu, et al.. (2021). GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease. Molecular Metabolism. 47. 101180–101180. 128 indexed citations
12.
Zheng, Jiaping, Fei Li, Yu Zhou, et al.. (2019). Lactoferrin improves cognitive function and attenuates brain senescence in aged mice. Journal of Functional Foods. 65. 103736–103736. 31 indexed citations
13.
Sun, Jianguo, et al.. (2017). Effects of Immunocytokine Combined with Cattle Encephalon Glycoside and Ignotin on CTGF, HO-1 and NT-3 in Patients with Type 2 Diabetic Peripheral Neuropathy.. PubMed. 46(12). 1632–1638. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026